Monitoring Agency Report for the quarter ended March 31, 2026.
DCXINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings has submitted its monitoring agency report for both DCX's IPO (Rs.400 crore raised in Oct-Nov 2022) and QIP (Rs.500 crore raised in Jan 2024). The IPO funds are nearly fully deployed (Rs.335.53 crore of Rs.373.03 crore), with Rs.37.50 crore remaining in fixed deposits awaiting GCP utilization by FY29. The QIP funds show slower progress — only Rs.209.72 crore deployed of Rs.486.65 crore; the Rs.200 crore JV investment and Rs.76.93 crore GCP remain largely unutilized as of March 2026. The company has established a JV named ELTX Systems Private Limited for radar manufacturing, with land allotted in Tamil Nadu, but formal approvals are still in progress. Management flagged that its Israel subsidiary Niart Systems reported a Rs.34.77 crore loss in 9MFY26 as it is still in R&D phase with no commercial production yet, creating credit risk if operations are further delayed.
The GCP funds for both issues are delayed beyond original timelines — now pushed to FY29. Slow JV ramp-up and Niart's continued losses may concern investors expecting near-term returns from capital raised in the QIP.